C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) A61K 31/397 (2006.01) A61K 31/4462 (2006.01) A61K 31/542 (2006.01) A61K 31/616 (2006.01) A61K 31/702 (2006.01) A61K 39/395 (2006.01) A61P 9/10 (2006.01)
Patent
CA 2686874
This invention relates to nucleotide polymorphisms in the human Apo(a) gene and to the use of Apo(a) nucleotide polymorphisms in identifying whether a human subject will respond or not to treatment with acetylsalicylic acid.
Cette invention porte sur des polymorphismes nucléotidiques dans le gène Apo(a) humain et sur l'utilisation de polymorphismes nucléotidiques de Apo(a) pour identifier si un sujet humain répondra ou non au traitement par l'acide acétylsalicylique.
Chasman Daniel
Ridker Paul
Shiffman Dov
Celera Corporation
Fetherstonhaugh & Co.
The Brigham And Women's Hospital Inc
LandOfFree
Polymorphism in the apo(a) gene predict responsiveness to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymorphism in the apo(a) gene predict responsiveness to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorphism in the apo(a) gene predict responsiveness to... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1726009